No Exit for Molecular Vision

Acrongenomics Inc. (OTC BB: AGNM) has canceled its proposed acquisition of Molecular Vision Ltd., a UK-based handheld diagnostic device company that had raised Gbp500,000 in seed funding from Imperial Innovations Group PLC. No explanation was provided. The two companies will continue to work on a joint development agreement, while Acrongenomics will retain a 10.9% ownership position in Molecular Vision that it recently acquired. www.molecularvision.co.uk